หน้าแรก
ค้นหา
Treatment of Newly Diagnosed Myeloma in Patients not Candidates for Transplantation
Myeloma Treatment. ESH. https://www.esh.org/conference/6th-transla...
แสดงข้อมูลเพิ่มเติม 1
Treatment of Newly Diagnosed Myeloma in Patients not Candidates for Transplantation
Data Shows Potential for Change in Standard of Care for Transplant-Ineligible Myeloma
Dr Facon on the Implications of Isatuximab Plus VRd in Transplant-Ineligible Newly Diagnosed Myeloma
Why do many patients not receive a transplant? #AML
Ask the Multiple Myeloma Experts 2020
MCRT Webinar May 2020: Round Table Audience Q&A – Session One Faculty
Managing Patients with NDMM
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma
Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer Institute
Updated analysis of MAIA: D-Rd continues to beat Rd in transplant-ineligible NDMM
Myeloma and Kidney Transplantation - UCSF Kidney Transplant Program Update in Transplantation 2019
Changing the standard of care for elderly multiple myeloma patients
Overall survival analysis from the ALCYONE trial in patients with transplant ineligible NDMM (ES)
New Patient Series: Blood & Marrow Transplants
Identifying and treating patients with high risk MM
Expert Cancer Panel: Relapsed, non-secretory multiple myeloma
Transplants for Older Adults: Who Is a Good Candidate? 2022
Multiple Myeloma: Stem Cell Transplant and Beyond 2021
CAR-T-cell Therapy for Multiple Myeloma: Who's A Good Candidate?
Maximilian Merz, MD on Vaccination After Transplant — IMW 2019
